| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 37.640 | 62.355 | 68.129 | 70.668 | 74.476 | 113.247 | 116.547 | 137.392 | 126.516 |
| Total Income - EUR | - | 37.640 | 62.356 | 68.131 | 70.670 | 75.625 | 113.364 | 116.550 | 137.395 | 127.869 |
| Total Expenses - EUR | - | 19.122 | 27.690 | 31.357 | 35.106 | 40.261 | 61.821 | 39.360 | 43.939 | 85.851 |
| Gross Profit/Loss - EUR | - | 18.519 | 34.666 | 36.774 | 35.564 | 35.364 | 51.543 | 77.189 | 93.456 | 42.018 |
| Net Profit/Loss - EUR | - | 18.142 | 34.042 | 36.097 | 34.858 | 34.713 | 50.757 | 76.199 | 92.109 | 38.758 |
| Employees | - | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Asiofta Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 2.817 | 3.033 | 3.410 | 28.773 | 24.268 | 9.123 | 7.320 | 7.897 | 5.767 |
| Current Assets | - | 17.940 | 38.555 | 70.406 | 93.724 | 23.717 | 77.008 | 75.833 | 94.440 | 49.740 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 312 | 162 | 168 | 361 | 770 | 6.321 | 377 | 33.259 | 1.407 |
| Cash | - | 17.628 | 38.393 | 70.238 | 93.362 | 22.947 | 70.687 | 75.456 | 40.964 | 13.344 |
| Shareholders Funds | - | 18.187 | 39.939 | 71.910 | 105.375 | 34.763 | 80.493 | 76.248 | 92.157 | 40.936 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.571 | 1.650 | 1.905 | 17.121 | 13.222 | 5.638 | 6.905 | 10.179 | 14.572 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Asiofta Med Srl